Synthesis and agonistic activity at the GPR35 of 5,6-dihydroxyindole-2- carboxylic acid analogues

ACS Medicinal Chemistry Letters

Volumn 3, Issue 7, 2012, Pages 550-554

  Deng, Huayun ^a   Fang, Ye ^a  

^a Corning Inc ^*  (United States)

Author keywords

5,6 dihydroxyindole 2 carboxylic acid; biased agonism; GPR35; melanin synthesis

Indexed keywords

5,6 DIHYDROXYINDOLE 2 CARBOXYLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BETA ARRESTIN; CARBOXYLIC ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 84863828527     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300076u     Document Type: Article

References (16)

1. MacKenzie, A. E.; Lappin, J. E.; Taylor, D. L.; Nicklin, S. A.; Milligan, G. GPR35 as a novel therapeutic target Front. Endocrin. 2011, 2, e68
2. Yang, Y.; Lu, J. Y. L.; Wu, X.; Summer, S.; Whoriskey, J.; Saris, C.; Reagan, J. D. G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium Pharmacology 2010, 86, 1-5
3. Yang, Y.; Fu, A.; Wu, X.; Reagan, J. D. GPR35 is a target of the loop diuretic drugs bumetanide and furosemide Pharmacology 2012, 89, 13-17
4. Deng, H.; Hu, H.; Fang, Y. Tyrphostin analogs are GPR35 agonists FEBS Lett. 2011, 585, 1957-1962
5. α13 Biochem. J. 2010, 432, 451-459
6. Deng, H.; Hu, H.; Ling, S.; Ferrie, A. M.; Fang, Y. Discovery of natural phenols as G protein-coupled receptor-35 (GPR35) agonists ACS Med. Chem. Lett. 2012, 3, 165-169
7. Deng, H.; Fang, Y. Anti-inflammatory gallic acid and wedelolactone are G protein-coupled receptor-35 agonists Pharmacology 2012, 89, 211-219
8. Wang, J.; Simonavicius, N.; Wu, X.; Swaminath, G.; Reagan, J.; Tian, H.; Ling, L. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J. Biol. Chem. 2006, 281, 22021-22028
9. Oka, S.; Ota, R.; Shima, M.; Yamashita, A.; Sugiura, T. GPR35 is a novel lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 2010, 395, 232-237
10. Deng, H.; Hu, H.; Fang, Y. Multiple tyrosine metabolites are GPR35 agonists Sci. Rep. 2012, 2, 373
11. Fang, Y.; Ferrie, A. M.; Fontaine, N. H.; Mauro, J.; Balakrishnan, J. Resonant waveguide grating biosensor for living cell sensing Biophys. J. 2006, 91, 1925-1940
12. Fang, Y. The development of label-free cellular assays for drug discovery Exp. Opin. Drug Discovery 2011, 6, 1285-1298
13. Deng, H.; Hu, H.; He, M.; Hu, J.; Niu, W.; Ferrie, A. M.; Fang, Y. Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor-35 (GPR35) agonists J. Med. Chem. 2011, 54, 7385-7396
14. Zhao, P.; Sharir, H.; Kapur, A.; Cowan, A.; Geller, E. B.; Adler, M. W.; Seltzman, H. H.; Reggio, P. H.; Heynen-Genel, S.; Sauer, M.; Chung, T. D. Y.; Bai, Y.; Chen, W.; Caron, M. G.; Barak, L. S.; Abood, M. E. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of ERK and β-arrestin2, with antinociceptive activity Mol. Pharmacol. 2010, 78, 560-568
15. Heynen-Genel, S.; Dahl, R.; Shi, S.; Sauer, M.; Hariharan, S.; Sergienko, E.; Dad, S.; Chung, T. D. Y.; Stonich, D.; Su, Y.; Caron, M.; Zhao, P.; Abood, M. E.; Barak, L. S. Antagonists for the orphan receptor GPR35. Probe Reports from the Molecular Libraries Program 2010; NBK5070.
16. Mailman, R. B. GPCR functional selectivity has therapeutic impact Trends Pharmacol. Sci. 2007, 28, 390-396